Correspondence
To add the references below to your reference management program: 1. Download the file; 2. Open your reference management program or EndNote; 3. Select File and import |
78 Articles |
-
Correspondence to “intranasal administration of Acinetobacter lwoffii in a murine model of asthma induces IL-6-mediated protection associated with cecal microbiota changes”
Chen, X. and He, Y.-q. Allergy. First published: 25 February 2024
-
Reply to Correspondence to “Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma—factor analysis”
Okada, N., Oguma, T. and Asano, K. Allergy. First published: 21 February 2024
-
Response to correspondence: Prediction of adult asthma risk in early childhood using novel adult asthma predictive risk scores
Farhan, A.J., Kothalawala, D.M., Kurukulaaratchy, R.J., et al. Allergy. First published: 08 February 2024
-
Correspondence to “Oral immunotherapy in alpha-gal red meat allergy: Could specific IgE be a potential biomarker in monitoring management?”
Chen, Y.-C., Lin, Y.-H., Lu, C.-T., Yii, C.-Y., Chen, P.-C. and Yong, S.-B. Allergy. First published: 13 February 2024
-
Reply to correspondence “Extracellular vesicle microRNA signatures as novel biomarkers in obese asthmatics”
Alhamdan, F., Potaczek, D.P., Greulich, T., Tost, J. and Garn, H. Allergy. First published: 29 January 2024
-
Correspondence to “Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma—Factor analysis”
Chang, K.-Y., Lu, C.-T., Yii, C.-Y. and Yong, S.-B.Allergy. First published: 16 January 2024
-
Correspondence to “Short-course subcutaneous treatment with PQ Grass strongly improves symptom and medication scores in grass allergy1”
Cheng, I.-H., Yii, C.-Y., Shih, L.-C. and Yong, S.-B. Allergy. First published: 16 January 2024
-
Reply to “European academy of allergy and clinical immunology, food allergy, anaphylaxis guidelines group. EAACI guidelines: Anaphylaxis (2021 update)”
Barroso, B., Gómez-López, A., Betancor, D., et al. Allergy. First published: 12 January 2024
-
Extracellular vesicle microRNA signatures as novel biomarkers in obese asthmatics
Sundar, I.K., Prasad, C. and Duraisamy, S.K. Allergy. First published: 21 December 2023
-
Correspondence to ‘association between chronic rhinosinusitis and new onset asthma implications for prevention’
Cheng, I., Yii, C.-Y., Shih, et al. Allergy. First published: 01 December 2023
-
Correspondence to “Basophil activation test as predictor of severity and threshold of allergic reactions to egg”
Ebo, D.G., Elst, J., Van Gasse, A.L., Mertens, C. and Sabato, V. Allergy. First published: 20 November 2023
-
Clinical applicability of the urticaria control test in patients with chronic urticaria: Further evidence from 622 adult and pediatric patients with different disease subtypes
Zhang, D.G., Sørensen, J.A., Ghazanfar, M.N. and Thomsen, S.F. Allergy. First published: 15 November 2023
-
Response to “clinical applicability of the Urticaria control test in patients with chronic urticaria: Further evidence from 622 adult and pediatric patients with different disease subtypes”
Gutsche, A., Salameh, P., Aulenbacher, F., et al. Allergy. First published: 03 November 2023
-
Sequential proteomic profiling of patients with Stevens–Johnson syndrome or toxic epidermal necrolysis
Contassot, E. and Brüggen, M.-C. Allergy. First published: 20 September 2023
-
Correspondence to “early infancy dysbiosis in food protein-induced enterocolitis syndrome: A prospective cohort study”
Hsu, Y.-S. and Yong, S.-B. Allergy. First published: 15 September 2023
-
Reply to correspondence to ‘Diagnosis of immediate reactions to amoxicillin: Comparison of basophil activation markers CD63 and CD203c in a prospective study’
Fernández, T.D., Mayorga, C. and Torres, M.J. Allergy. First published: 27 July 2023
-
Value of vaccine and vaccine excipient skin testing to COVID-19 vaccines
Brockow, K., Bent, R. and Biedermann, T. Allergy. First published: 30 June 2023
-
Practical conundrums of immune profiling in Stevens–Johnson syndrome-toxic epidermal necrolysis
Shah, S., Bishnoi, A., Vinay, K., et al. Allergy. First published: 14 June 2023
-
Reply to correspondence “Food allergens to emollients”
Irvine, A.D., Hourihane, J.O.B. and STOP-AD Team. Allergy. First published: 31 March 2023
-
Correspondence to “Diagnosis of immediate reactions to amoxicillin: Comparison of basophil activation markers CD63 and CD203c in a prospective study”
Elst, J., van der Poorten, M.-L.M., Toscano, A., et al. Allergy. First published: 30 March 2023
-
Importance of examining atopic dermatitis disease mechanisms in African populations
Lunjani, N., Akdis, C.A. and O'Mahony, L. Allergy. First published: 28 December 2022
-
Atopic dermatitis: The importance of future research in Africa
Fehr, D., Lang, C., Masenga, J., et al. Allergy. First published: 05 December 2022
-
COVID-19 pandemic and environment: Not only air pollution
Caminati, M., Guarnieri, G., Marchetti, P., et al. Allergy. First published: 28 November 2022
-
Basophil reactivity to BNT162b2 in COVID-19 convalescence
Perkins, G.B., Hurtado, P.R. and Hissaria, P. Allergy. First published: 28 November 2022
-
Reply to: “COVID-19 pandemic and environment: Not only air pollution.”
Fiorito, S., Soligo, M., Gao, Y., Ogulur, I., Akdis, C.A. and Bonini, S. Allergy. First published: 28 November 2022
-
Aspergillus fumigatus and personalized medicine: Toward a clinically reliable algorithm
Caminati, M., Feleszko, W., Michel, M., Annesi-Maesano, I., Vitte, J. Allergy. First published: 28 October 2022
-
Reply to “Aspergillus fumigatus and personalized medicine: Toward a clinically reliable algorithm”
Lukaszewicz, R., Mahay, G., Boyer, O. and Martinet, J. Allergy. First published: 28 October 2022
-
Is Helicobacter pylori infection inversely correlated with atopic, skin, and autoimmune diseases?
Yasuma, T., D’Alessandro-Gabazza, C.N., Fujimoto, H., et al. Allergy. First published: 28 September 2022
-
Reply to correspondence: “Is Helicobacter pylori infection inversely correlated with atopic, skin, and autoimmune diseases?”
Lee, H., Cho, S.I., Yang, M.-S., Cho, S.-J. and Lee, D.H. Allergy. First published: 28 September 2022
-
Correspondence to “Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus”
Smith, P.K., Lesslar, O. and Price, D.B. et al. Allergy. First published: 06 August 2022
-
Reply to correspondence to ‘Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus’
Hagemann, J., Zuberbier, T., Walter Canonica, G., et al. Allergy. First published: 06 August 2022
-
Bacillus Calmette–Guérin vaccination to prevent childhood asthma: A revised meta-analysis
Pittet, L.F. and Curtis, N. Allergy. First published: 30 June 2022
-
Reply to correspondence: Basophil reactivity to BNT162b2 in COVID-19 convalescence
Labella, M., Céspedes, J.A., Doña, I., et al. Allergy. First published: 30 June 2022
-
Comment on EAACI guideline: Anaphylaxis (2021 update)
Miceli Sopo, S., Sinatti, D., Mastellone, F., Bersani, G. and Gelsomino, M. et al. Allergy. First published: 30 June 2022
-
Reply to the correspondence: Bacillus Calmette-Guérin vaccination to prevent childhood asthma—A revised analysis
Navaratna, S., Burgess, J., Waidyatillake, N., et al. Allergy. First published: 30 June 2022
-
Reply to: “Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patients”
Renert-Yuval, Y. and Guttman-Yassky, E. Allergy. First published: 30 June 2022
-
Correspondence to " Emollients in infancy to prevent atopic dermatitis: A systematic review and meta-analysis"
Kelleher, M.M., Cro, S., Phillips, R., et al. Allergy. First published: 29 May 2022
-
Reply to correspondence: Emollients in infancy to prevent atopic dermatitis: A systematic review and meta-analysis
Zhong, Y., Samuel, M., van Bever, H. and Tham, E.H. Allergy. First published: 29 May 2022
-
Food-induced immediate response of the esophagus: A first report in the pediatric age
Votto, M., Naso, M., De Filippo, M., et al. Allergy. First published: 24 January 2022
-
Successful administration of second dose of BNT162b2 COVID-19 vaccine in two patients with potential anaphylaxis to first dose
Cahill, J.A. and Kan, M.sss Allergy. First published: 29 December 2021
-
β2-adrenergic agonists and doping: Where do we stand?
Lourenço, O., Cardoso, A., Mónico, B., Gama, J.M.R., Neiva, H.P. and Marinho, D.A. Allergy. 2021; 76: 2320-2321
-
Role of activation of the coagulation system in the pathogenesis of urticaria
Yasuma, T., D’Alessandro-Gabazza, C.N., Kobayashi, T., Morser, J. and Gabazza, E.C. Allergy. 2021; 76: 3243-3244
-
Silicosis: Pathogenesis and utility of animal models of disease
Walters, E.H. and Shukla, S.D. Allergy. 2021; 76: 3241-3242
-
Beta2-adrenergic agonists can enhance intense performance and muscle strength in healthy individuals
Hostrup, M., Jessen, S., Backer, V., Bangsbo, J. and Jacobson, G.A. Allergy. 2021; 76: 2318-2319
-
COVID-19 vaccines and the role of other potential allergenic components different from PEG. A reply to: “Other excipients than PEG might cause serious hypersensitivity reactions in COVID-19 vaccines”
Cabanillas, B., Akdis, C.A. and Novak, N. Allergy. 2021; 76: 1943-1944
-
Other excipients than PEG might cause serious hypersensitivity reactions in COVID-19 vaccines
Borgsteede, S.D., Geersing, T.H. and Tempels-Pavlica, Ž. Allergy. 2021; 76: 1941-1942
-
COVID-19 vaccine anaphylaxis: IgE, complement or what else? A reply to: “COVID-19 vaccine anaphylaxis: PEG or not?”
Cabanillas, B., Akdis, C.A. and Novak, N. Allergy. 2021; 76: 1938-1940
-
COVID-19 vaccine anaphylaxis: PEG or not?
Krantz, M.S., Liu, Y., Phillips, E.J. and Stone, C.A., Jr Allergy. 2021; 76: 1934-1937
-
Successful rapid desensitization in a glioma patient with procarbazine-mediated anaphylaxis
Hutten, E.M., Lambeck, A.J.A., Dijkstra, H., et al. Allergy. 2021; 76: 1932-1933
-
Reply to “Acute scrotum in a 8- year- old Italian child caused by extraintestinal anisakiasis in a seaside area
Morishima, R. Allergy. 2021; 76: 1603-1603
-
Acute scrotum in a 8-year-old Italian child caused by extraintestinal anisakiasis in a seaside area
Centonze, A., Capillo, S., Mazzei, A., et al. Allergy. 2021; 76: 1601-1602
-
Reply to: “Include desensitization to radiocontrast media in the diagnostic algorithm”
Brockow, K. Allergy. 2021; 76: 1304-1305
-
Include desensitization to radiocontrast media in the diagnostic algorithm of radio contrast media hypersensitivity
Bjørbak Alnæs, M. Allergy. 2021; 76: 1302-1303
-
Reply to “Inferring clinical relevance of der p 23 from the restricted effect on treatment outcomes after tablet allergy immunotherapy”
Stranzl, T., Ipsen, H., Christensen, L.H., et al. Allergy. 2021; 76: 1300-1301
-
Inferring clinical relevance of Der p 23 from the restricted effect on treatment outcomes after tablet allergy immunotherapy
González-Pérez, R. and Poza-Guedes, P. Allergy. 2021; 76: 1298-1299
-
Asthmatic patients and COVID-19: Different disease course?
Alberca, R.W., Yendo, T., Aoki, V. and Sato, M.N. Allergy.2021; 76: 963-965
-
Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19?
Heffler, E., Detoraki, A., Contoli, M., et al. Allergy.2021; 76: 961-962
-
Are severe asthma patients at higher risk of developing severe outcomes from COVID-19?
Kow, C.S., Capstick, T. and Hasan, S.S. Allergy.2021; 76: 959-960
-
Dupilumab, severe asthma airway responses, and SARS-CoV-2 serology
Bhalla, A., Mukherjee, M., Radford, K., et al. Allergy.2021; 76: 957-958
-
Asthma phenotypes, comorbidities, and disease activity in COVID-19: The need of risk stratification
Carli, G., Cecchi, L., Stebbing, J., Parronchi, P. and Farsi, A. Allergy.2021; 76: 955-956
-
Update on asthma prevalence in severe COVID-19 patients
Morais-Almeida, M., Barbosa, M.T., Sousa, C.S., Aguiar, R. and Bousquet, J. Allergy.2021; 76: 953-954
-
Comment on: Bilò MB, Pravettoni V, Mauro M, Bonadonna P. Treating venom allergy during COVID-19 pandemic
Martínez-Lourido, E., Otero, A., Armisén, M. and Vidal, C. Allergy, 76: 951-952
-
Treating venom allergy during COVID-19 pandemic
Bilò, M.B., Pravettoni, V., Mauro, M. and Bonadonna, P. Allergy.2021; 76: 949-950
-
Reply to Dr. Vincenzo Patella et al. Could anti-tubercular vaccination protect against COVID-19 infection?
Ozdemir, C., Kucuksezer, U.C. and Tamay, Z.Ü. Allergy. 2021; 76: 946-948
-
Could anti-tubercular vaccination protect against COVID-19 infection?
Patella, V., Florio, G., Brancaccio, R. and Delfino, G. Allergy.2021; 76: 942-945
-
Reply to correspondence: Silica-related diseases in the modern world: A role for self-DNA sensing in lung inflammatory
Chambers, D.C. and Hoy, R.F. Allergy.2020; 75: 3011-3011
-
Silica-related diseases in the modern world: A role for self-DNA sensing in lung inflammatory diseases
Togbe, D., Benmerzoug, S., Jacobs, M., Ryffel, B. and Quesniaux, V.F.J. Allergy.2020; 75: 3009-3010
-
Preschool wheeze: Challenges and research prospects reply to: Dr Jartti and Colleagues; in response to our manuscript entitled: Medical algorithm: Diagnosis and treatment of preschool asthma
Bush, A. and Saglani, S. Allergy. 2020; 75: 2718-2718
-
Reply to: Medical algorithm: Diagnosis and treatment of preschool asthma
Jartti, T., Papadopoulos, N.G., Feleszko, W. Allergy.2020; 75: 2716-2717
-
Detection of peanut allergens in serum: circumventing the inhibitory effect of immunoglobulins
Koppelman, S.J., Witteveen, M., JanssenDuijghuijsen, L., Baumert, J.L., Witkamp, R.F. and van Norren, K. Allergy.2020; 75: 1835-1836
-
Relationship between early pubertal maturation and asthma: The role of adiposity rebound in early childhood
Chen, Y.-C. and Lee, Y.L. Allergy.2020; 75: 999-1000
-
Relationship between early pubertal maturation and asthma
Ichikawa, G., Arisaka, O., Nakayama, K., Koyama, S. and Yoshihara, S. Allergy.2020; 75: 998-998
-
Reply to correspondence: "Bronchiolitis needs a revisit: Distinguishing between virus entities and their treatments"
Manti, S., Licari, A., Leonardi, S., Marseglia, G.L. and Baraldi, E. Allergy.2020; 75: 1531-1532
-
Correspondence to "Bronchiolitis needs a revisit: Distinguishing between virus entities and their treatments"
Jartti, T., Smits, H.H., Bønnelykke, K., et al. Allergy.2020; 75: 1529-1530
-
Reply to: "Arginase inhibitors: An alternative in treatment of obese asthma?"
Meurs, H., Zaagsma, J., Maarsingh, H. and van Duin, M. Allergy.2020; 75: 1527-1528
-
Arginase inhibitors: An alternative in treatment of obese asthma?
Felix, M.M.R. and Kuschnir, F.C. Allergy.2020; 75: 1525-1526
-
Role of routine cephalosporin allergy testing in surgical site infection reduction bundles
Fox, W.E. and Scott, M.J.Allergy.2019; 74: 1820-1820
-
Stability of neuromuscular blocking drugs used for skin testing
Baldo B. A. Allergy.2019; 74: 1201-1202